NLS Pharmaceutics ( (NLSP) ) has provided an announcement.
NLS Pharmaceutics Ltd., a Swiss-based company, convened an extraordinary shareholders’ meeting where all agenda items were approved except for Proposal 6, which was not voted on. This development indicates the company’s ability to successfully address shareholder concerns and may influence its future strategic decisions, affecting its market positioning and stakeholder relations.
More about NLS Pharmaceutics
YTD Price Performance: -4.13%
Average Trading Volume: 747,862
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.17M
For detailed information about NLSP stock, go to TipRanks’ Stock Analysis page.